Articles

Tech template: DMetrix, BioImagene team with IBM

IBM, array-microscope technology developer DMetrix and BioImagene, recently announced that ultra-rapid whole-slide imaging and large-scale scientific image management have been integrated for first time.
Written byJeffrey Bouley
| 3 min read

TUCSON, Ariz.—IBM, array-microscope technology developer DMetrix and San Mateo, Calif.-based life sciences and pharmaceutical image informatics solution provider BioImagene, recently announced that ultra-rapid whole-slide imaging and large-scale scientific image management have been integrated for first time.

The work on the "Arizona system," as DMetrix and BioImagene call it, is designed to accommodate as much as 33 terabytes of image data and manage more than 100,000 high-resolution images and was completed at The Arizona Cancer Center.

Perhaps just as important as bringing a substantial bit of business to DMetrix, BioImagene and IBM—which worked closely together but billed their services separately—this deployment can serve as a guide and example for other organizations to adopt for image handling functions and for the three companies to team together again, says Dr. Michael R. Descour, president of DMetrix.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.